Homerton Healthcare NHS Foundation Trust has become the first organisation anywhere in the NHS to deploy Sectra's enterprise imaging service using public cloud.

The deployment has shown that NHS patient imaging can be efficiently accessed from a secure public cloud environment, just as quickly as when data is stored on-premise.

A systemic cause of patient harm could be better avoided with the help of technology, following the launch of Miya Results Tracking by health tech company Alcidion.

The new digital solution is designed to reduce the risk of test results not being followed up. It has been built to help healthcare professionals in hospital settings to more easily visualise, prioritise and acknowledge high volumes of tests results generated for patients every day, and to take appropriate action in a timely manner.

Bayer moves ahead with advancements across its comprehensive Radiology portfolio as well as expanded offering in its digital business and services. The company announced that new clinical and pre-clinical data for gadoquatrane, Bayer's novel investigational macrocyclic gadolinium-based contrast agent currently in Phase III clinical development, will be presented at the 2024 European Congress of Radiology (ECR) - taking place from February 28 to March 3, 2024, in Vienna, Austria.

The trust's Oldham laboratory has completed technical go-live, with its Salford site also set to follow. Collectively the laboratories provide a wide range of general and specialist pathology services that support diagnoses for patients in the region. This includes one of the largest dermatology departments in the country, and gynaecology services that cover six hospitals.

Highland Marketing has been looking ahead to 2024 and asking health tech leaders what they expect to see in health tech this year. The chair of the advisory board, Jeremy Nettle, argues that with a general election approaching, the NHS needs a period of stability to address the pressures it is facing.

Antibodies are an important tool in the human immune system's arsenal against disease. They attach to bacteria, viruses, fungi, or toxins, marking them for destruction or removal from the body.

It is this ability to recognise and mark foreign and harmful molecules and organisms that allows therapeutic use of antibodies, including treating or preventing diseases such as cancer, as well as auto-immune and metabolic diseases.

The state of NHS infrastructure and legacy systems has started to attract attention from organisations worried about falling productivity. The Highland Marketing advisory board asked what it will take to fix the issues, against a backdrop of more funding being diverted from digital to "the frontline."

The NHS is heading for a significant financial squeeze, with its already tight 2021 Budget settlement eroded by inflation and the bill for a year of strikes - which has come in at around £1 billion.